Literature DB >> 9441942

Multidrug resistant proteins.

P Borst1.   

Abstract

Mesh:

Substances:

Year:  1997        PMID: 9441942     DOI: 10.1006/scbi.1997.0072

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


× No keyword cloud information.
  8 in total

Review 1.  Changes in lipid and protein constituents of rafts and caveolae in multidrug resistant cancer cells and their functional consequences.

Authors:  Y Lavie; M Liscovitch
Journal:  Glycoconj J       Date:  2000 Mar-Apr       Impact factor: 2.916

2.  Small molecules that dramatically alter multidrug resistance phenotype by modulating the substrate specificity of P-glycoprotein.

Authors:  R V Kondratov; P G Komarov; Y Becker; A Ewenson; A V Gudkov
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-13       Impact factor: 11.205

3.  Transport activity of human MRP3 expressed in Sf9 cells: comparative studies with rat MRP3.

Authors:  Hidetaka Akita; Hiroshi Suzuki; Tomoko Hirohashi; Hajime Takikawa; Yuichi Sugiyama
Journal:  Pharm Res       Date:  2002-01       Impact factor: 4.200

4.  Comparative analysis of CK2 expression and function in tumor cell lines displaying sensitivity vs. resistance to chemical induced apoptosis.

Authors:  Giovanni Di Maira; Francesca Brustolon; Kendra Tosoni; Sara Belli; Stefanie D Krämer; Lorenzo A Pinna; Maria Ruzzene
Journal:  Mol Cell Biochem       Date:  2008-06-17       Impact factor: 3.396

5.  Human immunodeficiency virus protease inhibitors serve as substrates for multidrug transporter proteins MDR1 and MRP1 but retain antiviral efficacy in cell lines expressing these transporters.

Authors:  R V Srinivas; D Middlemas; P Flynn; A Fridland
Journal:  Antimicrob Agents Chemother       Date:  1998-12       Impact factor: 5.191

6.  Depletion of mitochondrial DNA up-regulates the expression of MDR1 gene via an increase in mRNA stability.

Authors:  Wan Lee; Hyo Im Choi; Mi Jin Kim; Seung Yoon Park
Journal:  Exp Mol Med       Date:  2008-02-29       Impact factor: 8.718

Review 7.  Changes in membrane microdomains and caveolae constituents in multidrug-resistant cancer cells.

Authors:  Y Lavie; G Fiucci; M Czarny; M Liscovitch
Journal:  Lipids       Date:  1999       Impact factor: 1.646

Review 8.  6-(7-nitro-2,1,3-benzoxadiazol-4-ylthio) hexanol: a promising new anticancer compound.

Authors:  Huan-Huan Sha; Zhen Wang; Shu-Chen Dong; Tian-Mu Hu; Si-Wen Liu; Jun-Ying Zhang; Yang Wu; Rong Ma; Jian-Zhong Wu; Dan Chen; Ji-Feng Feng
Journal:  Biosci Rep       Date:  2018-02-13       Impact factor: 3.840

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.